Background:
Left ventricular (LV) apical aneurysms occur in a subset of patients with hypertrophic cardiomyopathy (HCM) and have been associated with ventricular arrhythmias and sudden cardiac death. However, the independent thromboembolic risk attributable to LV aneurysm in HCM, particularly in the absence of atria...
Sammudeen Ibrahim, Zakia Mohammed, H. Noureldine et al.· Circulation· 0 citations
Introduction:
Optimal antithrombotic management following transcatheter aortic valve replacement (TAVR) in patients with pre-existing indications for chronic oral anticoagulation (OAC) remains poorly defined. Current evidence, including the POPular TAVI trial, suggests OAC monotherapy may be sufficient, yet combinat...
H. N. Pham, M. Abdelnabi, Ramzi Ibrahim et al.· Circulation· 0 citations
Background:
Post-thrombotic syndrome (PTS) is a common chronic complication following acute deep vein thrombosis (DVT), affecting up to 20-50% of patients and leading to impaired quality of life and increased healthcare utilization. While direct oral anticoagulants (DOACs) are widely used for venous thromboembolism...
A. Abdelkhalek, I. Ogieuhi, E. Okorigba et al.· Circulation· 0 citations
The association between elevated Lp(a) and VTE appears limited to case-control studies and is not supported by prospective cohort data, suggesting potential bias or residual confounding.
M. Abdelnabi, C. Puchongmart, Ramzi Ibrahim et al.· Atherosclerosis· 0 citations
3-month DAPT followed by monotherapy significantly reduces bleeding without increasing ischemic events and crosses the futility boundary for MACCE and the benefit boundary for CRB, indicating conclusive evidence for bleeding reduction and futility for ischemic benefit.
C. Chinnatambi, Abdul Rahaman Ottun, Louise Sakowski et al.· Cardiovascular Revasculariza...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.